Daniel Cua Merck & Co., Inc., MRL, Palo Alto, USA, USA,
1 protocol

David Bauché
  • Research scientist, Merck & Co., Inc., MRL, South San Francisco, USA, USA,
Research focus
  • Immunology
  • Immunology, Oncology, Autoimmunity
  • 1 Author merit


Ph.D, University of Lyon, 2015

Lab information

Alissa Chackerian Lba


1 Protocol published
Induction and Analysis of Anti-CD40-induced Colitis in Mice
Authors:  Barbara Joyce-Shaikh, Daniel J. Cua and David Bauché, date: 02/05/2019, view: 6383, Q&A: 0
Colon inflammation or colitis affects more than 1 million people worldwide. Several pre-clinical models, including chemical-induced (i.e., DSS, TNBS) or pathogen-induced (i.e., Citrobacter rodentium) have been used to ...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.